 |
14 Diseases |  |
0 Trials |
|
0 Trials |  |
5 News |  |
- MDX-1342 / BMS
Trial initiation date: MDX1342-02: Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) (clinicaltrials.gov) - May 20, 2013
P1, N=15, Completed, Sponsor: Bristol-Myers Squibb
Initiation date: Feb 2008 --> Aug 2008
- MDX-1342 / BMS
Enrollment change, Combination therapy: MDX1342-01: Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - May 20, 2013
P1, N=26, Completed, Sponsor: Bristol-Myers Squibb
Initiation date: Feb 2008 --> Aug 2008 N=50 --> 26
- MDX-1342 / BMS
Enrollment change: MDX1342-02: Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) (clinicaltrials.gov) - May 20, 2013
P1, N=15, Completed, Sponsor: Bristol-Myers Squibb
N=50 --> 26 N=46 --> 15
- | MDX-1342 / BMS
Trial completion, Combination therapy: MDX1342-01: Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - May 20, 2013
P1, N=26, Completed, Sponsor: Bristol-Myers Squibb
N=46 --> 15 Suspended --> Completed
- | MDX-1342 / BMS
Trial completion: MDX1342-02: Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) (clinicaltrials.gov) - May 20, 2013
P1, N=15, Completed, Sponsor: Bristol-Myers Squibb
Suspended --> Completed Suspended --> Completed